107 related articles for article (PubMed ID: 11889597)
1. Loss of nuclear BRCA1 localization in breast carcinoma is age dependent.
Bogdani M; Teugels E; De Grève J; Bourgain C; Neyns B; Pipeleers-Marichal M
Virchows Arch; 2002 Mar; 440(3):274-9. PubMed ID: 11889597
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of BRCA1 protein in tumor breast tissue: prescreening of BRCA1 mutation in Tunisian patients with hereditary breast cancer?
Troudi W; Uhrhammer N; Ben Romdhane K; Sibille C; Mahfoudh W; Chouchane L; Ben Ayed F; Bignon YJ; Ben Ammar Elgaaied A
Eur J Histochem; 2007; 51(3):219-26. PubMed ID: 17921118
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
4. Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization.
Kainu T; Kononen J; Johansson O; Olsson H; Borg A ; Isola J
Cancer Res; 1996 Jul; 56(13):2912-5. PubMed ID: 8674039
[TBL] [Abstract][Full Text] [Related]
5. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 in non-inherited breast carcinomas (Review).
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043
[TBL] [Abstract][Full Text] [Related]
7. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.
Yoshikawa K; Honda K; Inamoto T; Shinohara H; Yamauchi A; Suga K; Okuyama T; Shimada T; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Clin Cancer Res; 1999 Jun; 5(6):1249-61. PubMed ID: 10389907
[TBL] [Abstract][Full Text] [Related]
8. Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers.
De Brakeleer S; Bogdani M; De Grève J; Decock J; Sermijn E; Bonduelle M; Goelen G; Teugels E
Mutat Res; 2007 Jun; 619(1-2):104-12. PubMed ID: 17445839
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of BRCA1 protein in invasive ductal carcinoma of the breast.
Burkadze G; Khardzeishvili O; Gudadze M; Tsikhiseli G; Turashvili G
Georgian Med News; 2010; (184-185):51-60. PubMed ID: 20834076
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
[TBL] [Abstract][Full Text] [Related]
11. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.
Wilson CA; Ramos L; Villaseñor MR; Anders KH; Press MF; Clarke K; Karlan B; Chen JJ; Scully R; Livingston D; Zuch RH; Kanter MH; Cohen S; Calzone FJ; Slamon DJ
Nat Genet; 1999 Feb; 21(2):236-40. PubMed ID: 9988281
[TBL] [Abstract][Full Text] [Related]
12. Correlation between morphology, immunohistochemistry and molecular pathology in hereditary and sporadic breast cancer cases.
Hadjisavvas A; Mikellidou C; Zenios A; Zouvani I; Adamou A; Christodoulou Ch; Kyriacou K
Ultrastruct Pathol; 2002; 26(4):237-44. PubMed ID: 12227949
[TBL] [Abstract][Full Text] [Related]
13. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.
Beger C; Ramadani M; Meyer S; Leder G; Krüger M; Welte K; Gansauge F; Beger HG
Clin Cancer Res; 2004 Jun; 10(11):3780-7. PubMed ID: 15173085
[TBL] [Abstract][Full Text] [Related]
15. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
16. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
Favy DA; Lafarge S; Rio P; Vissac C; Bignon YJ; Bernard-Gallon D
Biochem Biophys Res Commun; 2000 Jul; 274(1):73-8. PubMed ID: 10903898
[TBL] [Abstract][Full Text] [Related]
17. Expression of BRCA1, HER-1 (EGFR) and HER-2 in sporadic breast cancer and relationships to other clinicopathological prognostic features.
Ansquer Y; Mandelbrot L; Lehy T; Salomon L; Dhainaut C; Madelenat P; Feldmann G; Walker F
Anticancer Res; 2005; 25(6C):4535-41. PubMed ID: 16334138
[TBL] [Abstract][Full Text] [Related]
18. High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer.
Kristiansen M; Knudsen GP; Maguire P; Margolin S; Pedersen J; Lindblom A; Ørstavik KH
J Med Genet; 2005 Nov; 42(11):877-80. PubMed ID: 15879497
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Seo JH; Cho DY; Ahn SH; Yoon KS; Kang CS; Cho HM; Lee HS; Choe JJ; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS; Son GS; Lee JB; Koo BH
Hum Mutat; 2004 Oct; 24(4):350. PubMed ID: 15365993
[TBL] [Abstract][Full Text] [Related]
20. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
